This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Don B. Smith, MD
Englewood, Colo

JAMA. 1989;261(20):2952.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply. —

Although it makes no claim to completeness, the Physicians' Desk Reference does serve as a kind of pharmaceutical "who's who." The absence of a Jname, generic or proprietary, among the more than 2000 products in the 1988 edition spawned several explanatory theories.

Personally, I thought it was an aversion on the part of American medicine to words that might be even remotely juridical. J is just too prominent in "judge," "jury," and "jurisprudence."

Dr Fogel's kind offer to trade drugs for Caribbean real estate might not be necessary. The 1989 Physicians' Desk Reference lists both Janimine and Jevity. This is probably all the J-drugs a country needs, but I suspect we could handle more if our Canadian colleagues would like to trade J-drugs for JDs. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?